Comments on “Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)”

Detalles Bibliográficos
Autores principales: Ozyurek, Yasin, Sari, Sezin Yuce, Hurmuz, Pervin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897284/
https://www.ncbi.nlm.nih.gov/pubmed/35259417
http://dx.doi.org/10.1016/j.radonc.2022.02.035
_version_ 1784663357983293440
author Ozyurek, Yasin
Sari, Sezin Yuce
Hurmuz, Pervin
author_facet Ozyurek, Yasin
Sari, Sezin Yuce
Hurmuz, Pervin
author_sort Ozyurek, Yasin
collection PubMed
description
format Online
Article
Text
id pubmed-8897284
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-88972842022-03-07 Comments on “Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)” Ozyurek, Yasin Sari, Sezin Yuce Hurmuz, Pervin Radiother Oncol Letter to the Editor Elsevier B.V. 2022-05 2022-03-05 /pmc/articles/PMC8897284/ /pubmed/35259417 http://dx.doi.org/10.1016/j.radonc.2022.02.035 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Ozyurek, Yasin
Sari, Sezin Yuce
Hurmuz, Pervin
Comments on “Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)”
title Comments on “Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)”
title_full Comments on “Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)”
title_fullStr Comments on “Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)”
title_full_unstemmed Comments on “Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)”
title_short Comments on “Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)”
title_sort comments on “whole lung irradiation as a novel treatment for covid-19: final results of the prospective randomized trial (wincovid trial)”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897284/
https://www.ncbi.nlm.nih.gov/pubmed/35259417
http://dx.doi.org/10.1016/j.radonc.2022.02.035
work_keys_str_mv AT ozyurekyasin commentsonwholelungirradiationasanoveltreatmentforcovid19finalresultsoftheprospectiverandomizedtrialwincovidtrial
AT sarisezinyuce commentsonwholelungirradiationasanoveltreatmentforcovid19finalresultsoftheprospectiverandomizedtrialwincovidtrial
AT hurmuzpervin commentsonwholelungirradiationasanoveltreatmentforcovid19finalresultsoftheprospectiverandomizedtrialwincovidtrial

Ejemplares similares